Oncopeptides AB had a revenue of 19.18M in the quarter ending Jun 30, 2025, with 44.59%. This bring the company's revenue in the last twelve months to 50.87M, Decreased 27.68%. In the fiscal year ending Dec 31, 2024, Oncopeptides AB had annual revenue of 31.65M with -10.14% growth.